| Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer RE Reiter, Z Gu, T Watabe, G Thomas, K Szigeti, E Davis, M Wahl, ... Proceedings of the National Academy of Sciences 95 (4), 1735-1740, 1998 | 1024 | 1998 |
| Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression YE Whang, X Wu, H Suzuki, RE Reiter, C Tran, RL Vessella, JW Said, ... Proceedings of the National Academy of Sciences 95 (9), 5246-5250, 1998 | 896 | 1998 |
| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 704 | 2018 |
| Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial WP Fendler, J Calais, M Eiber, RR Flavell, A Mishoe, FY Feng, ... JAMA oncology 5 (6), 856-863, 2019 | 676 | 2019 |
| Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer Z Gu, G Thomas, J Yamashiro, IP Shintaku, F Dorey, A Raitano, ON Witte, ... Oncogene 19 (10), 1288-1296, 2000 | 654 | 2000 |
| Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT M Eiber, K Herrmann, J Calais, B Hadaschik, FL Giesel, M Hartenbach, ... Journal of Nuclear Medicine 59 (3), 469-478, 2018 | 537 | 2018 |
| Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology JD Le, N Tan, E Shkolyar, DY Lu, L Kwan, LS Marks, J Huang, ... European urology 67 (3), 569-576, 2015 | 524 | 2015 |
| Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice KA Klein, RE Reiter, J Redula, H Moradi, XL Zhu, AR Brothman, DJ Lamb, ... Nature medicine 3 (4), 402-408, 1997 | 499 | 1997 |
| Value of targeted prostate biopsy using magnetic resonance–ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen GA Sonn, E Chang, S Natarajan, DJ Margolis, M Macairan, P Lieu, ... European urology 65 (4), 809-815, 2014 | 495 | 2014 |
| Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: the role of systematic and targeted biopsies CP Filson, S Natarajan, DJA Margolis, J Huang, P Lieu, FJ Dorey, ... Cancer 122 (6), 884-892, 2016 | 482 | 2016 |
| 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging … J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ... The Lancet Oncology 20 (9), 1286-1294, 2019 | 417 | 2019 |
| Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process N Craft, C Chhor, C Tran, A Belldegrun, J DeKernion, ON Witte, J Said, ... Cancer research 59 (19), 5030-5036, 1999 | 411 | 1999 |
| Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma P Argani, C Rosty, RE Reiter, RE Wilentz, SR Murugesan, SD Leach, ... Cancer research 61 (11), 4320-4324, 2001 | 408 | 2001 |
| Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ... JNCI: Journal of the National Cancer Institute 109 (12), djx118, 2017 | 407 | 2017 |
| Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance H Tanaka, E Kono, CP Tran, H Miyazaki, J Yamashiro, T Shimomura, ... Nature medicine 16 (12), 1414-1420, 2010 | 394 | 2010 |
| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 384 | 2020 |
| Low p27 expression predicts poor disease-free survival in patients with prostate cancer RM YANG, J NAITOH, M MURPHY, HEJ WANG, J PHILLIPSON, ... The Journal of urology 159 (3), 941-945, 1998 | 381 | 1998 |
| NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ... Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021 | 376 | 2021 |
| Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 … AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ... Jama 319 (9), 896-905, 2018 | 322 | 2018 |
| Quality of life after surgery, external beam irradiation, or brachytherapy for early‐stage prostate cancer MS Litwin, JL Gore, L Kwan, JM Brandeis, SP Lee, HR Withers, RE Reiter Cancer 109 (11), 2239-2247, 2007 | 314 | 2007 |
